We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory panel is recommending that the anti-inflammatory drug Celebrex be approved for use in treating juvenile rheumatoid arthritis (JRA) — despite a virtual split among its members as to whether the drug would be safe in treating the disease. Read More
In an effort to reduce management and process deficiencies and expedite new product reviews, the Swiss Agency for Therapeutic Products (Swissmedic) is reorganizing its Institute Council, which oversees all agency activities.
The use of genetic testing to develop personalized dosing for medicines can save lives and potentially billions of dollars, a group of FDA officials says.
The use of genetic testing to develop personalized dosing for medicines can save lives and potentially billions of dollars, a group of FDA officials says.
The FDA’s decision to place a hold on a clinical trial is threatening HHS’ contract with VaxGen for the development of a stockpile of anthrax vaccines.
A group of medical officials in Washington state has created a proposal that suggests a maximum daily dosage of narcotic painkillers in an attempt to prevent accidental deaths from overdose.
There is a large gap between public health policy and the scientific evidence for influenza vaccines, and the government programs should be reevaluated due to the amount of resources involved in flu preparedness, according to a recent medical journal article.
Wholesalers are scrambling to find a strategy to stop the FDA from implementing a drug tracking rule they say will allow a few large companies to monopolize the market, forcing smaller competitors out of business.
CVS and Caremark Rx are joining in a stock-for-stock “merger of equals,” a move that will combine one of the nation’s leading pharmaceutical services companies with the largest retail pharmacy chain.